医生Covid-19治疗信息

Banner Health is offering monoclonal antibody infusions in our outpatient infusion centers for patients who are eligible for treatment. View ourCOVID-19 Monoclonal Antibody Infusion OrderandCOVID-19 Monoclonal Antibody Infusion Order。这些抗体治疗尚未批准, but have been authorized for emergency use by the FDA, to treat mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older, weighing at least 40 kg) with positive results of SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization. This authorization is only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of these antibodies under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

You can refer a patient by following these steps, which does include completing either theCOVID-19 Monoclonal Antibody Infusion OrderorCOVID-19 Monoclonal Antibody Infusion Orderand faxing to an outpatient infusion center currently offering this treatment, along with these documents, which must be completed and signed by a physician, physician assistant or nurse practitioner.

1. Clinical note
2. COVID lab result
3. Patient demographic information

Patient Referral Process for Monoclonal Antibody Treatment

有关FDA的紧急使用授权的信息casirivimab/imdevimabcan be found on the FDA’s website.

To refer an eligible patient for monoclonal antibody treatment, you must have:

• Patient has documentation of a positive PCR or direct antigen COVID test.
• Confirm that your patient is at least 12 years old and have mild to moderate COVID-19 symptoms that began less than 10 days ago.
• 确认您的患者患有严重症状或需要住院的高风险。
• Evaluate and identify what high-risk criteria is present with the patient, options include:
  • Age 65 or greater
  • Pregnant
  • 慢性肾病
  • Diabetes
  • 免疫抑制疾病，或您接受免疫抑制治疗
  • Cardiovascular disease
  • Hypertension
  • Chronic lung disease such as COPD or cystic fibrosis
  • Sickle cell disease
  • Neurodevelopmental disorders or other medically complex conditions such as genetic conditions or metabolic syndrome
  • Medical-related technology dependence such as a feeding tube
  • Other medical conditions or factors, such as race or ethnicity, can also put you at high risk for developing severe COVID-19 infection.
• 没有资格接受单克隆抗体治疗治疗的患者是：
  • Asymptomatic patients
  • If your patient has been hospitalized for COVID
  • Has any other systemic infection
  • Has received oxygen therapy due to COVID or requires additional oxygen if on chronic oxygen therapy.
• 审查EUA患者的情况表，包括将接受单克隆抗体治疗的患者的风险和益处。可以使用下面的链接找到信息。
  
  • Casirivimab/imdevimab
• Complete a Clinical Note that indicates which high-risk factors the patient has, as well as documentation that you reviewed risks and benefits with the patient.
• Complete theCOVID-19 Monoclonal Antibody Infusion OrderorCOVID-19 Monoclonal Antibody Infusion Orderand fax, along with the following documentation, to the preferred Banner Health outpatient infusion site.